VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr | ₹350 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹267 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹301 Cr |
Mar2021 | ₹322 Cr |
Mar2020 | ₹350 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹267 Cr | -3.93 | |
Mar2023 | ₹278 Cr | -7.59 | |
Mar2022 | ₹301 Cr | -6.44 | |
Mar2021 | ₹322 Cr | -7.99 | |
Mar2020 | ₹350 Cr | - |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹482.5 Cr | 24.5% | 21.8% | -9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 24.5% |
21.8% |
-9.1% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses